CD274 and nasopharyngeal carcinoma: As depicted by the findings displayed in Figure 4, studies related to immunotherapy for NPC have mainly focused on adoptive immunotherapy for EBV-CTLs, radiotherapy, and PD-L1/PD-1 therapy.